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is it time to move to an individualized approach?
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See related research by Xu et al., http://ccforum.com/content/19/1/130Abstract
Xu and colleagues evaluated the impact of
increasing mean arterial blood pressure levels
through norepinephrine administration on systemic
hemodynamics, tissue perfusion, and sublingual
microcirculation of septic shock patients with chronic
hypertension. The authors concluded that, although
increasing arterial blood pressure improved sublingual
microcirculation parameters, no concomitant
improvement in systemic tissue perfusion indicators
was found. Here, we discuss why resuscitation targets
may need to be individualized, taking into account the
patient’s baseline condition, and present directions for
future research in this field.concurrent control group. Therefore, it is not possible
to rule out the role of chance (that is, the possibilityCommentary
In a recent article in Critical Care, Xu and colleagues [1]
evaluated the impact of increasing mean arterial blood
pressure (MAP) levels from around 70 mmHg, through
norepinephrine administration, on systemic hemodynamics,
tissue perfusion, and sublingual microcirculation of 19
septic shock patients with chronic hypertension. The target
MAP was defined as the patient’s average usual blood
pressure in the previous 2 years. Increasing MAP improved
sublingual microcirculation parameters without concomi-
tant improvement in systemic tissue perfusion indicators
(arterial pH, lactate, and urinary output) [1].
The concept of individualizing the MAP targets for
patients with septic shock is certainly laudable. Several
aspects of the study design and methodology should be
considered in the interpretation of the results. First,
patients were enrolled in a late phase of resuscitation,
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(http://creativecommons.org/publicdomain/zewith an unknown period of time spent with an MAP
under 65 mmHg [1]. In experimental sepsis, increasing the
delay between sepsis onset and the resuscitation maneuvers
increases severity of sepsis and need for resuscitation [2].
Thus, one could argue that earlier microcirculation recruit-
ment in such patients with hypertension would have been
associated with better results in terms of tissue perfusion
and outcomes. Second, the time between the baseline mea-
surements and the second measurements at the patients’
usual MAP levels was only 50 min [1]. Any improvement
in variables reflecting organ perfusion and metabolism is
unlikely in such a short window of time if microcirculation
in areas other than the sublingual region indeed did
improve. Finally, as stressed by the authors, this was
a single-center prospective open-label study without a
that the observed improvement in microcirculatory
parameters occurred by chance or as a consequence
of the natural evolution of the disease).
In a recent large trial on septic shock, more than 40 %
of patients had a history of chronic hypertension [3].
Patients with chronic hypertension usually need higher
MAP levels than patients without hypertension to achieve
and maintain an adequate perfusion pressure to the vital
organs [4] and therefore their MAP goals may need to be
revised [5].
Small prospective cohort studies [6–9] and two
randomized studies [3, 10] addressed the impact of
different MAP levels on tissue perfusion, organ function,
sublingual microcirculation, and outcomes in patients
with septic shock. The main findings of these studies
were recently reviewed elsewhere [11]. The SEPSISPAM
(Assessment of Two Levels of Arterial Pressure on
Survival in Patients With Septic Shock Study) study
included 776 patients with septic shock and demonstrated
that higher MAP targets (80 to 85 mmHg) in comparison
with conventional targets (65 to 70 mmHg) did not
improve survival or the need for renal replacement therapyticle distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in
operly credited. The Creative Commons Public Domain Dedication waiver
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above the goal blood pressure range during the 5 protocol-
specified days. Nevertheless, when the subgroup of patients
with chronic hypertension was analyzed, targeting a higher
MAP decreased the need for renal replacement therapy
[3]. We recently demonstrated in a long-term porcine
fecal peritonitis model that MAP targets between 75
to 85 mmHg compared with 50 to 60 mmHg did not
improve global or regional hemodynamics but did decrease
the incidence of acute kidney injury [12].
Taken together, the available evidence reveals that
targeting higher MAP levels during the initial resuscitation
of septic shock has variable effects on microcirculatory
parameters and organ function, which may also be de-
pendent on patients’ usual blood pressure level. However,
it should be noted that targeting higher blood pressure
increases patients’ exposure to fluids and vasopressors,
which may have detrimental effects [13].
What do we learn from the study by Xu and colleagues?
It is well known that patients admitted to the intensive
care unit vary widely in terms of age, number and type of
comorbidities, and functional status [14]. Such variability
may explain, at least in part, the failure in translating
many advances in basic science to clinical practice and
why we have to face so many negative results in large
sepsis multicenter randomized clinical trials [15]. Therefore,
as proposed by Xu and colleagues, resuscitation targets
may have to be individualized, taking into account the
patient’s baseline condition [1].
Further research is needed to address the impact of
individualized MAP targets on tissue perfusion, organ
function, inflammatory response, and exposure to vasopres-
sors and fluids and, more importantly, on the outcomes.
The development of new technologies may help clinicians
to evaluate, at the bedside, the impact of achieved
MAP targets on microcirculatory parameters and organ
function. Finally, the individualized approach may allow
us to identify non-hypertensive patients who may tolerate
lower mean arterial and perfusion pressure levels to main-
tain their organs’ function. In such patients, a decreased
exposure to vasopressors may limit their side effects and
improve outcomes.
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